Viewpoint on handling anti-TNF failure in psoriasis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Dermatology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00403-013-1418-6.pdf
Reference26 articles.
1. (EMEA) EAftEoMP (2007) Guideline on immunogenicity assessment of biotechnology-derived therapeutic proteins. EMEA/CHMP/BMWP/14327/2006
2. Afif W, Loftus EV Jr, Faubion WA, Kane SV, Bruining DH, Hanson KA, Sandborn WJ (2010) Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease. Am J Gastroenterol 105(5):1133–1139
3. Bartelds GM, Wijbrandts CA, Nurmohamed MT, Stapel S, Lems WF, Aarden L, Dijkmans BA, Tak PP, Wolbink GJ (2010) Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study. Ann Rheum Dis 69(5):817–821
4. Chavez-Lopez MA, Delgado-Villafana J, Gallaga A, Huerta-Yanez G (2005) Severe anaphylactic reaction during the second infusion of infliximab in a patient with psoriatic arthritis. Allergol Immunopathol (Madr) 33(5):291–292
5. Daien CI, Daien V, Parussini E, Dupuy AM, Combe B, Morel J (2012) Etanercept concentration in patients with rheumatoid arthritis and its potential influence on treatment decisions: a pilot study. J Rheumatol 39(8):1533–1538
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Promising Tools to Facilitate the Implementation of TDM of Biologics in Clinical Practice;Journal of Clinical Medicine;2022-05-26
2. Multiple drugs;Reactions Weekly;2021-09
3. Association between infliximab concentrations and clinical response in psoriasis: a prospective cohort study;Journal of Dermatological Treatment;2019-11-20
4. 31-Year-Old Female with Psoriasis on Adalimumab with Loss of Effect;Clinical Cases in Psoriasis;2019
5. Secondary failure of TNF-α inhibitors in clinical practice;Dermatologic Therapy;2018-11-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3